Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

37
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
37
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Mitochondrial Membranes01:45

Mitochondrial Membranes

11.7K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson's disease.

NPJ Parkinson's disease·2024
Same author

The PINK1 kinase-driven ubiquitin ligase Parkin promotes mitochondrial protein import through the presequence pathway in living cells.

Scientific reports·2019
Same author

Ubiquitylome profiling of Parkin-null brain reveals dysregulation of calcium homeostasis factors ATP1A2, Hippocalcin and GNA11, reflected by altered firing of noradrenergic neurons.

Neurobiology of disease·2019
Same author

The genetic landscape of Parkinson's disease.

Revue neurologique·2018
Same author

Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.

Scientific reports·2017
Same author

The Autosomal Recessive Form of CMT Disease Linked to 5q31-q33.

Annals of the New York Academy of Sciences·2017

Related Experiment Video

Updated: May 7, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K

Mitochondrial dysfunctions in Parkinson's disease.

C A Gautier1, O Corti1, A Brice2

  • 1Inserm, U 975, CRICM, hôpital de la Pitié-Salpêtrière, 75013 Paris, France; UPMC Université Paris 06, UMR_S975, 75013 Paris, France; CNRS, UMR 7225, 75013 Paris, France.

Revue Neurologique
|October 15, 2013
PubMed
Summary

Mitochondrial dysfunction is increasingly implicated in neurodegenerative disorders like Parkinson's disease (PD). Research suggests these cellular energy problems may be a primary cause of neuronal death in PD, offering new therapeutic targets.

Keywords:
Disease modelsMaladie de ParkinsonMitochondriaMitochondrieModèles animauxOxidative stressParkinson's DiseaseStress oxydant

More Related Videos

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

1.9K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

6.3K

Related Experiment Videos

Last Updated: May 7, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

1.9K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

6.3K

Area of Science:

  • Neurobiology
  • Mitochondrial Medicine
  • Neurodegenerative Diseases

Background:

  • Neurodegenerative disorders (ND) represent a significant global health and economic burden, characterized by progressive neuronal dysfunction.
  • While ND are heterogeneous, emerging evidence highlights the central role of mitochondrial dysfunction in their pathogenesis.
  • Parkinson's disease (PD) is a prime example, with studies showing mitochondrial impairment and oxidative damage in affected brains.

Purpose of the Study:

  • To critically analyze the experimental evidence supporting a mitochondrial origin for Parkinson's disease.
  • To evaluate the relevance of mitochondrial dysfunction in PD pathogenesis for understanding neurodegeneration broadly.
  • To explore genetic and environmental factors linked to PD that impact mitochondrial function.

Main Methods:

  • Review of post-mortem studies on idiopathic Parkinson's disease brains.
  • Analysis of cellular and animal models mimicking genetic and environmental PD insults.
  • Critical evaluation of experimental data linking mitochondrial impairment to dopaminergic degeneration.

Main Results:

  • Consistent findings of mitochondrial impairment, including reduced complex I activity, in Parkinson's disease.
  • Genetic and environmental factors associated with PD often converge on pathways affecting mitochondrial integrity and function.
  • Studies on PD models strongly implicate mitochondrial dysfunction in the selective loss of dopaminergic neurons.

Conclusions:

  • Mitochondrial dysfunction plays a seminal role in the pathogenesis of Parkinson's disease, potentially serving as a primary cause.
  • Understanding the mitochondrial basis of PD offers crucial insights into idiopathic forms of the disease.
  • Further research into mitochondrial mechanisms in PD could reveal novel therapeutic strategies for neurodegenerative disorders.